Healthcare · Drug Manufacturers - General

Pfizer Ltd.

PFIZER

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

NSE: PFIZEROfficial website ↗

Key metrics

Market Cap

₹22,273 cr

P/E Ratio

26.11x

P/B Ratio

5.28x

ROE

18.2%

ROCE

23.68%

Debt / Equity

0.03x

Net Margin

33.65%

Dividend Yield

72%

EPS

₹167.79

Period

FY2025

Shareholding pattern

As of Latest

Promoter: 66.98%FII: 16.82%Public: 16.20%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→

Educational content — not investment adviceThis page presents publicly available information about Pfizer Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.